This intratumoral hypoxia induces HIF-1α and HIF-2α protein expression, and an upregulation in the expression of one or both of these proteins is linked with increased patient mortality in a wide range of solid cancers and leukemias, as detected by immunohistochemical analysis of the diagnostic tumor biopsies [73]. The gene discussed is HIF1A; the disease is neoplasm.